Resultados de procura - Judi van Diessen
- Mostrando 1 - 6 Resultados de 6
-
1
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas por J.F. Van den Hoek, Karen Bloemendal, Lilly-Ann van der Velden, Judi van Diessen, Erik van Werkhoven, W. Martin C. Klop, Margot Tesselaar
Publicado 2016Artigo -
2
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial) por Judi van Diessen, Dirk De Ruysscher, Jan‐Jakob Sonke, E. Damen, Karolina Sikorska, Bart Reymen, Wouter van Elmpt, Gunnar Westman, G. Persson, Edith Dieleman, Hedvig Björkestrand, Corinne Faivre‐Finn, J. Belderbos
Publicado 2018Artigo -
3
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab por Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos
Publicado 2016Artigo -
4
Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer por Rosemarie de Haan, Michel M. van den Heuvel, Judi van Diessen, Heike Peulen, Erik van Werkhoven, Adrianus J. de Langen, Ferry Lalezari, Dick Pluim, Manon Verwijs-Janssen, Conchita Vens, Jan H.M. Schellens, Neeltje Steeghs, Marcel Verheij, Baukelien van Triest
Publicado 2020Artigo -
5
Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety... por Judith A. E. M. Zecha, Judith E. Raber‐Durlacher, Raj Nair, Joel B. Epstein, Stephen T. Sonis, Elad Sharon, Michael R. Hamblin, Andrei Barasch, César A. Migliorati, Dan M.J. Milstein, Marie-Thérèse Genot, Liset Lansaat, Ron van der Brink, Josep Arnabat‐Domínguez, Lisette van der Molen, Irene Jacobi, Judi van Diessen, Jan de Lange, Ludi E. Smeele, Mark M. Schubert, René‐Jean Bensadoun
Publicado 2016Revisão -
6
Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocol... por Judith A. E. M. Zecha, Judith E. Raber‐Durlacher, Raj Nair, Joel B. Epstein, Sharon Elad, Michael R. Hamblin, Andrei Barasch, César A. Migliorati, Dan M.J. Milstein, Marie-Thérèse Genot, Liset Lansaat, Ron van der Brink, Josep Arnabat‐Domínguez, Lisette van der Molen, Irene Jacobi, Judi van Diessen, Jan de Lange, Ludi E. Smeele, Mark M. Schubert, René‐Jean Bensadoun
Publicado 2016Revisão
Ferramentas de procura:
Materias Relacionadas
Internal medicine
Medicine
Oncology
Radiation therapy
Cancer
Chemotherapy
Head and neck
Head and neck cancer
Surgery
Toxicity
Biology
Chemoradiotherapy
Cisplatin
Laser
Laser therapy
Low level laser therapy
Lung cancer
Mucositis
Optics
Physics
Randomized controlled trial
Regimen
Adverse effect
Anesthesiology
Biochemistry
Bioinformatics
Breast cancer
Cancer therapy
Cancer treatment
Cetuximab